Stent thrombosis: a contemporary guide to definitions, risk factors, and management
Frontiers in Cardiovascular Medicine · 21.10.2025 · 12
DOI: 10.3389/fcvm.2025.1622235 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.10.2025. Verfasst von Ambre Flowers und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Emory University, Atlanta, GA, United States. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stent thrombosis remains a major complication following percutaneous coronary intervention, with significant morbidity and mortality implications. Despite advancements in drug-eluting stents and optimized pharmacotherapy, real-world registry data indicate that definite or probable stent thrombosis occurs in approximately 0.5% of percutaneous coronary intervention cases, with a 30-day mortality rate approaching 25% and a long-term risk exceeding 30% at 10 years. Stent thrombosis is classified based on timing into acute, subacute, late, and very late thrombosis, with subacute and very late stent thrombosis being the most prevalent. Clinical consequences include myocardial infarction, emergent revascularization, and heightened cardiovascular risk, necessitating timely recognition and intervention. Risk factors include patient characteristics, procedural variables, and lesion complexity, with recurrent stent thrombosis remaining a notable concern. This review explores the definitions, classifications, pathophysiology, and risk factors for stent thrombosis while discussing current strategies for prevention and management. Additionally, advancements in stent technology and pharmacologic interventions are examined, underscoring the need for a multidisciplinary approach to mitigate stent thrombosis incidence and improve patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Emory University, Atlanta, GA, United States.
- School of Medicine, University of Mississippi Medical Center, Jackson, MS, United States.
- Departmemnt of Internal Medicine, Baylor College of Medicine, Houston, TX, United States.
- Department of Internal Medicine, Mobile Infirmary Medical Center, Mobile, AL, United States.
- Harrington Heart & Vascular Institute, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
- Department of Cardiology, Texas Heart Institute and Baylor College of Medicine, Houston, TX, United States.
Zitieren
APA
Flowers, A., Evenhuis, B., Gabanic, B., Weiss, A., Eisenberg, S., Siddiqui, R., Rizwan, A., Riaz, I., Hassan Virk, H. U., Alam, M., Khawaja, M., Strauss, M., & Krittanawong, C. (2025). Stent thrombosis: a contemporary guide to definitions, risk factors, and management. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1622235
Vancouver
Flowers A, Evenhuis B, Gabanic B, Weiss A, Eisenberg S, Siddiqui R, et al. Stent thrombosis: a contemporary guide to definitions, risk factors, and management. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1622235
BibTeX
@article{Flowers2025,
author = {Flowers, Ambre and Evenhuis, Bernard and Gabanic, Benjamin and Weiss, Allison and Eisenberg, Scott and Siddiqui, Riyan and Rizwan, Affan and Riaz, Iqra and Hassan Virk, Hafeez Ul and Alam, Mahboob and Khawaja, Muzamil and Strauss, Markus and Krittanawong, Chayakrit},
title = {Stent thrombosis: a contemporary guide to definitions, risk factors, and management},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1622235}
}
EUVIMED